Skip to content

Clinical trials

Terminated Observational Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Observational Status: Terminated Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20093
20105
20111
20121
20151
20171
20192
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Azienda USL Reggio Emilia - IRCCS1
Bayer1
Baylor College of Medicine1
Boston Scientific Corporation1
Centre Hospitalier Universitaire de Saint Etienne1
Centre Oscar Lambret1
Dartmouth-Hitchcock Medical Center1
Fate Therapeutics1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell20
Kidney Neoplasms4
Colorectal Neoplasms3
Carcinoma2
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Liver Neoplasms2
Melanoma2
Pancreatic Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.